Protein Biomarkers Enable Sensitive and Specific Cervical Intraepithelial Neoplasia (CIN) II/III+ Detection: One Step Closer to Universal Cervical Cancer Screening
The quantitative analysis of these biomarkers, along with the subsequent sensitive and specific clinical classification, highlights their potential application in SIL early detection and CC prevention, particularly in LMICs.
Authors
- Samrin F. Habbani (ORCID: https://orcid.org/0000-0002-4359-1301)
- Meaghan M. Broman (ORCID: https://orcid.org/0000-0001-5473-1616)
- Scott C. Bolton (ORCID: https://orcid.org/0000-0002-6592-1455)
- Lucy Tecle
- Sayeh Dowlatshahi (ORCID: https://orcid.org/0000-0001-8011-9471)
- Jacqueline C. Linnes (ORCID: https://orcid.org/0000-0003-4962-0908)
- Lisa Flowers
- Nathanael I. Lichti (ORCID: https://orcid.org/0000-0003-2487-0708)
- Sulma I. Mohammed (ORCID: https://orcid.org/0000-0002-6031-3442)
- Rafael Guerrero‐Preston (ORCID: https://orcid.org/0000-0002-3069-9583)
Institutions
- Emory University (US)
- Purdue University West Lafayette (US)
- University of Florida Health (US)
- UF Health Cancer Center
Publication Details
- Journal
- Cancers
- Published
- 2025-05-24
- DOI
- https://doi.org/10.3390/cancers17111763
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Purdue University
- National Institutes of Health
- College of Veterinary Medicine, Purdue University
- National Cancer Institute
- National Institute on Minority Health and Health Disparities